Navigation Links
Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints
Date:1/8/2009

ty is a public health crisis, with more than 70 million Americans considered to be obese, according to the Centers for Disease Control. It is a chronic disease that is linked to serious medical conditions such as Type 2 diabetes, heart disease, blood pressure, stroke, depression and some forms of cancer. Obesity results from an energy imbalance associated with various environmental, behavioral and genetic factors making it a difficult and complicated condition to treat. However, there is a growing understanding of how the central nervous system regulates appetite and metabolism as well as the mechanisms that limit weight loss over time. This understanding is the basis of new strategies in drug development that we believe have the potential to change the way obesity is treated.

About Contrave

Contrave is an investigational oral weight loss medication with a unique mechanism of action that works at two levels within the central nervous system: one designed to control the balance of food intake and metabolism and another designed to control food preference, reward and cravings. We believe that Contrave may be the first treatment for obesity to target these reward centers in the central nervous system. Based on clinical trials completed to date, Contrave is believed to initiate and sustain significant weight loss over one year of treatment by reducing appetite, increasing metabolism and allowing the body to continue losing weight by offsetting its natural tendency to fight back and slow down the weight loss process.

About Orexigen(R) Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead combination product candidates targeted for obesity are Contrave, which is in Phase 3 clinical trials, and Empatic(TM), which is in the later stages of Phase 2 clinical development. Each product candidate is designed to act on
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)
2. Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results
3. Orexigen(R) Therapeutics Initiates First Clinical Trial of OREX-003 for the Mitigation of Antipsychotic-Associated Weight Gain
4. Orexigen(R) Therapeutics Appoints Dennis Kim, M.D., as Senior Vice President, Head of Obesity and Metabolic Disorders
5. Orexigen(R) Therapeutics to Present at Upcoming Investor Conferences
6. Orexigen(R) Therapeutics Schedules Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2008
7. OREXIGEN(R) Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003
8. InteKrin Therapeutics to Present at the 27th Annual JP Morgan Healthcare Conference on Tuesday, January 13
9. Aegera Therapeutics Initiates A Randomized Phase 2 Combination Study of AEG35156 for 1st Line Treatment of Non-Small Cell Lung Cancer
10. Amicus Therapeutics Adds Sol J. Barer, Ph.D. to Board of Directors
11. Cell Therapeutics Announces Receipt of NASDAQ Panel Decision to Transfer to NASDAQ Capital Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Woburn, MA (PRWEB) September 18, 2014 ... Single Molecule Sequencing (tSMS™) technology, announced today the ... round of investment, led by Genomic Diagnostic Technologies, ... scientific and diagnostic applications. , Founded in March ... Scientist and Bioinformatics Analyst at Helicos BioSciences, SeqLL ...
(Date:9/18/2014)... pretty expensive. Now a team led by an engineer ... of designs that will let scientists slash the cost ... pump. , Syringe pumps are used to dispatch precise ... chemicals in a reaction. They can also cost hundreds ... his team of Michigan Tech students published the library ...
(Date:9/18/2014)... developed a new microscopy technology that allows them ... higher-than-ever resolution. , Dubbed "Complementation Activated Light Microscopy" ... are an order of magnitude finer than conventional ... of biomolecules at the nanometer scale. , In ... Nature Communications , the researchers behind CALM used ...
(Date:9/18/2014)... device for computing may have just taken an encouraging ... York led by chemist Stephen O,Brien have discovered new ... , Combining both properties is very exciting scientifically for ... the devices that might ultimately be designed, in logic ... single material, however, has proved difficult until now. , ...
Breaking Biology Technology:SeqLL Closes Series-A Funding Round for Expansion of Single Molecule Sequencing 2Doing science just got cheaper -- and faster 2Scientists pioneer microscopy technique that yields fresh data on muscular dystrophy 2Oxides discovered by CCNY team could advance memory devices 2
... ... a case study that provides a sustainable solution for odor and ... effectivness of beneficial microbial applications. These results are intended to address ... Agency, who recently agreed to identify and investigate thousands of factory ...
... June 24 Spanish biotechnology company Progenika Biopharma, ... Grifols exclusive world-wide distribution rights for its BLOODCHIP® molecular biology ... to assure the compatibility of blood for transfusion between donor ... , ...
... June 22 Netsmart Technologies, a leading ... services organizations, today announced an agreement with Genstar Capital, ... Genstar will provide the capital and strategic healthcare expertise ... solutions to meet the needs of its customers in ...
Cached Biology Technology:Effective Odor and Pathogen Control in Livestock Operations Revealed in New Case Study 2Progenika Biopharma Grants Grifols World-Wide Distribution Rights for the BLOODCHIP® Genotyping Test for Blood Donors 2Progenika Biopharma Grants Grifols World-Wide Distribution Rights for the BLOODCHIP® Genotyping Test for Blood Donors 3Netsmart Technologies and Genstar Capital Announce Investor Partnership 2Netsmart Technologies and Genstar Capital Announce Investor Partnership 3Netsmart Technologies and Genstar Capital Announce Investor Partnership 4Netsmart Technologies and Genstar Capital Announce Investor Partnership 5
(Date:9/18/2014)... clownfish larvae can swim up to 400 kilometres in search ... with environmental change. , Clownfish spend their entire adult lives ... they must wander the open ocean, says study co-author, Dr ... Reef Studies (Coral CoE) at James Cook University. , "In ... we,ve been given a rare glimpse into how far they ...
(Date:9/17/2014)... affordable health care to reproductive technologies, the justice ... ability of people to identify key issues, articulate ... and find the most defensible ways forward. But ... these societal conversations?, The Hastings Center and the ... have teamed up to publish a series of ...
(Date:9/17/2014)... Humanities has received a $260,000 grant from the Andrew ... of the Human in the Age of the Life ... of events aimed at exploring two compelling themes in ... who are exploring the boundaries of our self-definition as ... other involves the increasingly influential hypothesis that we are ...
Breaking Biology News(10 mins):Nemo's epic journey to find a new home 2Why bioethics literacy matters 2Why bioethics literacy matters 3Mellon Foundation awards grant for major project in the humanities and sciences 2
... vehicle exhaust pipes could soon provide a valuable supply ... researchers working under the Australian Research Council (ARC) Centre ... ionic liquid-based thermocell. Thermocells are based on harnessing the ... surfaces and converting that energy into electrical energy. ...
... those that are sceptical about weight loss products that may or ... for you. While some products do not work at all and ... is working a product that appears to be ahead of the ... heard many claims before so what does OxyELITE Pro do that ...
... of biomedical science both mystifying and awe-inspiring to the ... that can,t be easily seen, like the inner-workings of cells, ... research authored by Thomas Sladewski, a University of Vermont graduate ... colleagues, provides a rare "picture" of the activity taking place ...
Cached Biology News:Ionic liquid breakthrough in thermal electrical energy 2Prohormonesdirect.com Offers in Depth OxyELITE Pro Reviews 2Scientists construct visual of intracellular 'zip code' signaling linked to learning, memory 2Scientists construct visual of intracellular 'zip code' signaling linked to learning, memory 3
Umbilical cord blood CD14+ Monocytes, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Human peripheral blood basophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes...
Umbilical cord blood CD19+ B cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Human peripheral blood neutrophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes...
Biology Products: